Archive for April, 2011
Understanding Low Acceptance Rates Of Pediatric Flu Vaccination Could Help Increase Coverage
A study of H1N1 and seasonal influenza vaccination in a sample of black and Hispanic children in Atlanta found a low rate of vaccine acceptance among parents and caregivers. Only 36 percent of parents and caregivers indicated they would immunize children against H1N1, and 22 percent indicated their children received the seasonal influenza vaccine in the previous three months…
CAREC: There is no swine flu outbreak in region
BRIDGETOWN, Barbados (CMC) — On the heels of a Swine Flu alert by the Pan America Health Organisation (PAHO), the Trinidad and Tobago-based Caribbean Epidemiology Centre (CAREC) yesterday assured that there was no outbreak of the H1N1 virus commonly known as Swine Flu in the Caribbean.
Sanofi-Aventis Earnings Drop 29 Percent in First Quarter on Loss of Swine Flu Vaccine Sales
From Canadian Press DataFile (April 28, 2011)
PARIS — Sanofi-Aventis SA says its earnings fell by nearly 30
per cent in the first quarter as low swine flu vaccine sales
battered the French drug maker’s bottom line.
The world’s fourth largest… (Source: Drugs.com – Pharma News)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Sanofi Profit Dips on Generic Competition, Pandemic Flu End
Sanofi-Aventis SA, the French drugmaker that bought Genzyme Corp. this month, said first- quarter profit fell as generic competition dented sales of five key medicines and the end of the pandemic wiped out demand for swine flu vaccines.
Sanofi-Aventis earnings drop 29 per cent in 1st quarter on loss of swine flu vaccine sales
PARIS – Sanofi-Aventis SA says its earnings fell by nearly 30 per cent in the first quarter as low swine flu vaccine sales battered the French drug maker’s bottom line.
Sanofi First-Quarter Net Drops on Generics Competition, Pandemic Flu End
Sanofi-Aventis SA (SAN) , the French drugmaker that bought Genzyme Corp. (GENZ) this month, said first- quarter profit fell as generic competition dented sales of five key medicines and the end of the pandemic wiped out demand for swine flu vaccines.
Sanofi Profit Drops on Generics, Pandemic Flu End
Sanofi-Aventis SA, the French drugmaker that bought Genzyme Corp. this month, said first- quarter profit fell as generic competition dented sales of five key medicines and the end of the pandemic wiped out demand for swine flu vaccines.
CDC vaccine scientist who downplayed links to autism indicted by DOJ in alleged fraud scheme
This article goes on to say, by the way, that Thorsen was also working with the American Psychiatric Association (APA) to alter the definition of “autism” in the DSM-V (the psychiatric industry’s bible of diagnosis and treatment).The CDC, of course, has downplayed the whole thing. It released a statement that attempted to characterize Poul Thorsen’s alleged fraud as a “fiscal” matter, not something involving his science, as if to imply that a man can be a crook when it comes to his money, but an angel when it comes to his science.They said:”CDC is aware of the allegations by Aarhus University against Poul Thorsen, a Danish doctor who participated in CDC funded research. For the past 10 years, CDC has had a cooperative agreement with the Danish Agency for Science, Technology and Innovation …
Government starts listening to patients
Nick Clegg, Paul Burstow and Andrew Lansley embark on listening tourRelated items from OnMedicaReferrals cost £15bn despite management centresPatients to be offered free choice of GPCollaboration vital in health reformWhite Paper goes too far too fastGovernment announces swine flu review (Source: OnMedica Latest News)
For Egg-Allergic Kids, One-Dose Flu Shot May Be Safe
Children with egg allergies may be able to safely get their flu shot in one dose, just like other kids, a new study suggests
